Cosmos Pharmaceutical Corp
TSE:3349
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmos Pharmaceutical Corp
TSE:3349
|
JP |
|
G
|
George Weston Ltd
F:WX5
|
CA |
|
Sonoco Products Co
NYSE:SON
|
US |
|
Persimmon PLC
F:OHP0
|
UK |
|
Option Care Health Inc
NASDAQ:OPCH
|
US |
Wall St Price Targets
Price Targets Summary
Cosmos Pharmaceutical Corp
According to Wall Street analysts, the average 1-year price target for
Cosmos Pharmaceutical Corp is 8 730.27 JPY with a low forecast of 6 363 JPY and a high forecast of 11 445 JPY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Cosmos Pharmaceutical Corp's stock price target?
Price Target
8 730.27
JPY
According to Wall Street analysts, the average 1-year price target for
Cosmos Pharmaceutical Corp is 8 730.27 JPY with a low forecast of 6 363 JPY and a high forecast of 11 445 JPY.
What is the Revenue forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 2 years is 10%.
What is the Pre-Tax Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Cosmos Pharmaceutical Corp?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 5%.